AI-Powered Robotic Platform
for high quality Prostate Cancer
Diagnosis & Focal Therapy
From biopsy to focal therapy — Delivering unmatched precision, affordability, and accessibility.
mission
To democratize access to early-stage prostate cancer care, by enabling every clinic—not just specialized centers—to deliver accurate diagnosis and focal therapies with simple and accessible AI-powered robotics.
A standalone robotic platform for diagnosis and Focal Therapy
REGOLUS delivers an AI-powered, robotic solution for prostate cancer diagnosis and treatment—cutting costs , eliminating delays, and ensuring precision care for all patients.
ENABLING A NEW PARADIGM FOR THOUSANDS OF PATIENTS EVERY YEAR
REGOLUS enhances diagnostic accuracy, supports accurate focal therapy for early stage cancer when radical surgery is not necessary, reduces misdiagnosis and overtreatment, while preserving the quality of life
REGOLUS Benefits for Patients
REGOLUS supports accurate diagnosis and needle-based focal therapies, providing an alternative to radical surgery. AI-powered targeting and robotic accuracy ensure error-free biopsy and enable focal therapy exactly where cancer was detected. Focal therapies enabled by REGOLUS are an alternative to early stage prostate cancer that avoid major surgery and their risks.
Meet The Innovators Behind Our Vision
